The department of Applied Tumor Biology investigates the molecular mechanisms of tumor development and progression. In patients’ diagnostics, analyses are performed for tumor classification and cancer early detection. In research, novel diagnostic markers and antigens, which are relevant for immunotherapy, are identified. Based on these markers, clinical studies are planned and performed. There is a close collaboration with different clinical and theoretical institutions as well as the National Center for Tumor Diseases (NCT), the German Cancer Research Center (DKFZ) and the European Molecular Biological Laboratory (EMBL), and several industrial partners. Our teaching activity comprises lectures, seminars, and colloquia in the field of applied tumor biology.
Director
Prof. M. von Knebel Doeberitz, MD
Im Neuenheimer Feld 224
69120 Heidelberg
Germany
Phone.: +49-6221-56-4220
Email: Magnus.Knebel-Doeberitz@med.uni-heidelberg.de
Secretariat:
A. Klingmann (Monday-Friday, 8:30 a.m. - 1:00 p.m.)
Phone.: 0049-6221-56-4221
Fax: 0049-6221-56-5981